BioWorld

Nov. 18, 2002

View Archived Issues

Confirmatory Phase III Prestara Protocol Submitted By Genelabs

Genelabs Technologies Inc. has laid the groundwork for a confirmatory Phase III trial of its lupus drug, Prestara, and said it expects to begin the trial before the end of the year. (BioWorld Today) Read More

NIH Awards Structural GenomiX Authority Over Protein Research

Read More

TransForm Pharmaceuticals, Weizmann Institute Align To Develop Better Malaria Drug

Read More

SuperGen Receives Approval For Supergeneric Mitozytrex

Read More

Medicon Valley Developing R&D Capabilities In Four Key Areas

Read More

ViroLogic Plans Cuts While It Raises $10M, Deals With Pfizer

Read More

Other News To Note

Read More